Progenics Pharmaceuticals (PGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 9,576 | 7,461 | 10,085 | 8,884 | 9,822 |
| Gross Profit | 9,576 | 7,461 | 10,085 | 8,884 | 9,822 |
| Operating Expenses | 52,343 | 39,068 | 34,180 | 23,933 | 19,772 |
| Operating Income | -42,767 | -31,607 | -24,095 | -15,050 | -9,949 |
| Interest Expense | 0 | 0 | 2 | 49 | 95 |
| Other Income | 749 | 621 | 3,308 | 13,200 | 4,127 |
| Pre-tax Income | -42,018 | -30,986 | -20,789 | -1,898 | -5,917 |
| Net Income Continuous | -42,018 | -30,986 | -20,789 | -1,898 | -5,917 |
| Net Income | $-42,018 | $-30,986 | $-20,789 | $-1,898 | $-5,917 |
| EPS Basic Total Ops | -2.48 | -2.32 | -1.66 | -0.15 | -0.49 |
| EPS Basic Continuous Ops | -2.48 | -2.32 | -1.66 | -0.15 | -0.49 |
| EPS Diluted Total Ops | -2.48 | -2.32 | -1.66 | -0.15 | -0.49 |
| EPS Diluted Continuous Ops | -2.48 | -2.32 | -1.66 | -0.15 | -0.49 |
| EBITDA(a) | $-40,109 | $-29,690 | $-21,799 | $-13,916 | $-8,716 |